Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 39, Issue 1, 2008, Pages 45-52

  Voltz, James W ^a   Card, Jeffrey W ^a   Carey, Michelle A ^a   DeGraff, Laura M ^a   Ferguson, Catherine D ^a   Flake, Gordon P ^a   Bonner, James C ^b   Korach, Kenneth S ^a   Zeldin, Darryl C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Bleomycin; Fibrosis; Respiratory mechanics; Sex

Indexed keywords

ANDROGEN; BLEOMYCIN; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING MECHANICS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYDROLYSIS; IN VIVO STUDY; LUNG FIBROSIS; LUNG FUNCTION; MALE; MOUSE; NONHUMAN; SEX DIFFERENCE;

ANIMALS; BLEOMYCIN; COLLAGEN; DIHYDROTESTOSTERONE; ESTRADIOL; FEMALE; INFLAMMATION; LUNG COMPLIANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORCHIECTOMY; OVARIECTOMY; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; RNA; SEX CHARACTERISTICS;

MUS;

EID: 45849086486     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0340OC     Document Type: Article

References (40)

1. Umezawa H, Maeda K, Takeuchi T, Okami Y. New antibiotics, bleomycin a and b. J Antibiot (Tokyo) 1966;19:200-209.
2. Advani R, Ai WZ, Horning SJ. Management of advanced stage hodgkin lymphoma. J Natl Compr Canc Netw 2006;4:241-247.
3. Diehl V, Behringer K. Could beacopp be the new standard for the treatment of advanced hodgkin's lymphoma (hl)? Cancer Invest 2006;24:713-717.
4. Huddart RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther 2005;5:123-138.
5. Kawai K, Akaza H. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer. Expert Opin Drug Saf 2003;2:587-596.
6. Uzel I, Ozguroglu M, Uzel B, Kaynak K, Demirhan O, Akman C, Oz F, Yaman M. Delayed onset bleomycin-induced pneumonitis. Urology 2005;66:195.
7. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: Searching for model answers. Am J Respir Cell Mol Biol 2005;33:9-13.
8. Wells AU, Hogaboam CM. Update in diffuse parenchymal lung disease 2006. Am J Respir Crit Care Med 2007;175:655-660.
9. Swigris JJ, Kuschner WG, Kelsey JL, Gould MK. Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest 2005;127:275-283.
10. Card JW, Voltz JW, Carey MA, Bradbury JA, Degraff LM, Lih FB, Bonner JC, Morgan DL, Flake GP, Zeldin DC. Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis. Am J Respir Cell Mol Biol 2007;37:300-308.
11. Lovgren AK, Jania LA, Hartney JM, Parsons KK, Audoly LP, Fitzgerald GA, Tilley SL, Koller BH. Cox-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2006;291:L144-L156.
12. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. The incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61:980-985.
13. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the united states from 1992 to 2003. Am J Respir Crit Care Med 2007;176:277-284.
14. Osman M. Therapeutic implications of sex differences in asthma and atopy. Arch Dis Child 2003;88:587-590.
15. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10:98-103.
16. Hewitt SC, Harrell JC, Korach KS. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 2005;67:285-308.
17. Wintermantel TM, Campbell RE, Porteous R, Bock D, Grone HJ, Todman MG, Korach KS, Greiner E, Perez CA, Schutz G, et al. Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin- releasing hormone neurons and fertility. Neuron 2006;52:271-280.
18. Carey MA, Card JW, Bradbury JA, Moorman MP, Haykal-Coates N, Gavett SH, Graves JP, Walker VR, Flake GP, Voltz JW, et al. Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am J Respir Crit Care Med 2007;175:126-135.
19. Salazar E, Knowles JH. An analysis of pressure-volume characteristics of the lungs. J Appl Physiol 1964;19:97-104.
20. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988;41:467-470.
21. Adamson IY. Drug-induced pulmonary fibrosis. Environ Health Perspect 1984;55:25-36.
22. Akiyama S, Ikezaki K, Kuramochi H, Takahashi K, Kuwano M. Bleomycin-resistant cells contain increased bleomycin-hydrolase activities. Biochem Biophys Res Commun 1981;101:55-60.
23. Lazo JS, Humphreys CJ. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc Natl Acad Sci USA 1983;80:3064-3068.
24. Lazo JS, Merrill WW, Pham ET, Lynch TJ, McCallister JD, Ingbar DH. Bleomycin hydrolase activity in pulmonary cells. J Pharmacol Exp Ther 1984;231:583-588.
25. Haston CK, Wang M, Dejournett RE, Zhou X, Ni D, Gu X, King TM, Weil MM, Newman RA, Amos CI, et al. Bleomycin hydrolase and a genetic locus within the mhc affect risk for pulmonary fibrosis in mice. Hum Mol Genet 2002;11:1855-1863.
26. Carey MA, Card JW, Voltz JW, Arbes SJ Jr, Germolec DR, Korach KS, Zeldin DC. It's all about sex: gender, lung development and lung disease. Trends Endocrinol Metab 2007;18:308-313.
27. Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007;293:L272-L278.
28. Card JW, Voltz JW, Ferguson CD, Carey MA, DeGraff LM, Peddada SD, Morgan DL, Zeldin DC. Male sex hormones promote vagally mediated reflex airway responsiveness to cholinergic stimulation. Am J Physiol Lung Cell Mol Physiol 2007;292:L908-L914.
29. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176:243-252.
30. Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH. Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 2005;166:1593-1606.
31. Sebti SM, Mignano JE, Jani JP, Srimatkandada S, Lazo JS. Bleomycin hydrolase: Molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry 1989;28:6544-6548.
32. Bromme D, Rossi AB, Smeekens SP, Anderson DC, Payan DG. Human bleomycin hydrolase: Molecular cloning, sequencing, functional expression, and enzymatic characterization. Biochemistry 1996;35:6706-6714.
33. Filderman AE, Genovese LA, Lazo JS. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochem Pharmacol 1988;37:1111-1116.
34. Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J, Lazo JS. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc Natl Acad Sci USA 1999;96:4680-4685.
35. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:639-644.
36. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB, et al. Idiopathic pulmonary fibrosis: Prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006;174:803-809.
37. Azoulay E, Herigault S, Levame M, Brochard L, Schlemmer B, Harf A, Delclaux C. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit Care Med 2003;31:1442-1448.
38. Gunther A, Lubke N, Ermert M, Schermuly RT, Weissmann N, Breithecker A, Markart P, Ruppert C, Quanz K, Ermert L, et al. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 2003;168:1358-1365.
39. Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, Cowley E, Hamilton TA, Eidelman DH, Stevenson MM, et al. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with pseudomonas aeruginosa in mice. Immunology 2002;107:297-305.
40. Card JW, Carey MA, Bradbury JA, DeGraff LM, Morgan DL, Moorman MP, Flake GP, Zeldin DC. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol 2006;177:621-630.